Compare

Turning Point Brands/$TPB

1D1W1M3M6MYTD1Y5YMAX

About Turning Point Brands

Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
Ticker
$TPB
Primary listing
NYSE
Employees
484

TPB Metrics

BasicAdvanced
$1.3B
28.82
$2.29
0.94
$0.32
0.49%

What the Analysts think about TPB

Analyst ratings (Buy, Hold, Sell) for Turning Point Brands stock.
Analyst projections of the future price of Turning Point Brands stock.

Bulls say / Bears say

Modern Oral is scaling rapidly: Q2 net sales rose 128% year on year to $68.4 million and reached 48% of company sales. TPB raised its 2026 Modern Oral sales guidance in August and reaffirmed it in September. (Turning Point Brands, Turning Point Brands)
More retail access could extend growth: management expects chain-store count to rise 70% year on year by the end of 2026, with new shelf placements rolling out over several quarters. It is also expanding its sales force to support FRE and ALP distribution. (Exa)
Planned US nicotine-pouch manufacturing could improve unit economics over time. Management says it expects lower costs once production is scaled, with gross margins potentially reaching about 70%, although regulatory approval is still required. (Exa)
Profitability is weakening as TPB funds growth: Q2 adjusted EBITDA fell 50% and net income fell 75% year on year, while SG&A more than doubled. In September, the company narrowed its 2026 EBITDA outlook to $70–80 million and said it assumes no manufacturing margin benefit until 2027 and prolonged higher freight costs. (Turning Point Brands, Turning Point Brands)
The established businesses are under pressure: Zig-Zag sales fell 24.8% year on year in Q2, while heritage Stoker’s sales slipped 1% as loose-leaf declines offset moist-snuff share gains. Continued weakness would leave more of the growth burden on the newer pouch business. (Turning Point Brands)
FDA approval remains a material uncertainty for the pouch opportunity. TPB said its PMTA application was still pending, and FDA rules require premarket authorisation to market new tobacco products; its enforcement guidance is conditional rather than an authorisation. (Turning Point Brands, FDA)
Data summarised monthly by Lightyear AI. Last updated on 18 Oct 2026.

TPB Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

TPB Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.